Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-cell Renal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06690697
What this trial is testing

Combination of Toripalimab and JS004 Therapy for ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Fudan University 80
Early research (Phase 1)Study completedNCT06840548
What this trial is testing

Evaluate the Safety and Dosimetry of 68Ga-OncoCAIX in Patients With CAIX-positive Cancer

Who this might be right for
Clear Cell Renal Cell Carcinoma (ccRCC)
Philogen S.p.A. 20
Testing effectiveness (Phase 2)Looking for participantsNCT06680089
What this trial is testing

CD70-targeted immunoPET Imaging of Kidney Cancer

Who this might be right for
Urologic NeoplasmsUrogenital NeoplasmsKidney Neoplasms+1 more
RenJi Hospital 300
Early research (Phase 1)Study completedNCT04496089
What this trial is testing

Evaluation of Safety, Biodistibution and Sensitivity/Specificity of PET/CT Imaging With 89Zr-TLX250 in Subjects With RCC

Who this might be right for
Carcinoma, Renal CellClear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited 6
Testing effectiveness (Phase 2)UnknownNCT04385654
What this trial is testing

Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma

Who this might be right for
Neoadjuvant TherapyAdvanced CancerMetastatic Kidney Cancer
West China Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00100906
What this trial is testing

Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer

Who this might be right for
Kidney Cancer
H. Lee Moffitt Cancer Center and Research Institute 18
Early research (Phase 1)Study completedNCT04374877
What this trial is testing

Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorClear Cell Renal Cell CarcinomaHepatocellular Carcinoma+1 more
Coherus Oncology, Inc. 145
Testing effectiveness (Phase 2)Ended earlyNCT00243009
What this trial is testing

Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery

Who this might be right for
Kidney Cancer
OHSU Knight Cancer Institute 1
Early research (Phase 1)Looking for participantsNCT07072234
What this trial is testing

Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell CarcinomaPhase 1Growth Factor
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)UnknownNCT01219751
What this trial is testing

Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Asan Medical Center 35
Not applicableUnknownNCT01512186
What this trial is testing

A Phase II Study Investigating Upfront Pazopanib In Metastatic Renal Cancer Renal Cancer (Panther)

Who this might be right for
Metastatic Clear Cell Renal Cancer
Queen Mary University of London 95
Very early researchStudy completedNCT00278369
What this trial is testing

Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer

Who this might be right for
Kidney Cancer
Northwestern University 20
Early research (Phase 1)UnknownNCT02497599
What this trial is testing

Intraoperative Dual-modality Imaging in Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Radboud University Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT03685448
What this trial is testing

ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)

Who this might be right for
Renal Cell CarcinomaPapillary Renal Cell Carcinoma Type 1Papillary Renal Cell Carcinoma Type 2+3 more
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 35
Testing effectiveness (Phase 2)Ended earlyNCT04904302
What this trial is testing

Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT06245915
What this trial is testing

AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)

Who this might be right for
Advanced/Metastatic Clear Cell Renal Cell CarcinomaRecurrence
Arsenal Biosciences, Inc. 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT03284385
What this trial is testing

Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Clear Cell Renal Cell CarcinomaLocally Advanced Malignant Solid Neoplasm+4 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Looking for participantsNCT06835972
What this trial is testing

Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

Who this might be right for
Metastatic Renal Cell CarcinomaTranslocation Renal Cell Carcinoma
Memorial Sloan Kettering Cancer Center 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07602101
What this trial is testing

Neoadjuvant PD-L1 Inhibitor Plus Anlotinib for Kidney Preservation in Complex Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
RenJi Hospital 33
Early research (Phase 1)Looking for participantsNCT05176483
What this trial is testing

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+8 more
Exelixis 1,394
Next Page